Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Lilly Expands Disease Management Program to Reach Growing Asian-American Population

Thu. October 29, 2009; Posted: 10:30 AM
Stocks RSS
INDIANAPOLIS, Oct 29, 2009 /PRNewswire-FirstCall via COMTEX/ -- LLY | Quote | Chart | News | PowerRating -- To expand its patient education outreach, Lilly is translating portions of its award-winning Health Education Answers program, an online health and wellness tool, into Mandarin - one of the most common languages spoken by Asian-Americans.

This will provide easy-to-access, interactive health information to Asian-Americans - one of the fastest growing ethnic groups in the United States, with an annual growth rate of 5.2 percent.(1) By the year 2050, the Asian-American population is expected to increase to 37.6 million, comprising 9.3 percent of the U.S. population.(2)

Already available in Spanish and English, Health Education Answers is a Web-based program designed to help managed care and public payer organizations further drive the standard of patient care through educational outreach. Patients accessing the program can progress through several health and disease management modules, including ADHD, Bipolar Disorder, Depression, Diabetes, Diabetes Complications, Manage Your Weight, Medication Safety, Men's Health, Schizophrenia, Smoking & Addictions, and Women's Health. The Diabetes, Women's Health and Smoking & Addictions modules are now available in Mandarin, and Lilly plans to translate the remaining modules in the future.

The Health Education Answers program addresses some of the most prevalent health conditions of Asian-Americans. According to several studies, Asian-Americans are almost twice as likely to develop diabetes as the general population in the United States.(3) In addition, Asian-Americans have had greater communication difficulties with their physicians, less access to preventative services and chronic disease care, and decreased satisfaction with the quality of their health care.(4)

"By providing Health Education Answers in Mandarin, the program will reach a broader Asian-American audience and offer them an interactive, easy-to-use tool to learn about health and wellness," said Alex M. Azar II, vice president, Lilly USA. "For nearly a decade, Lilly has funded disease management programs to help improve patient care and reduce overall health care costs. We're proud to continue this outreach by expanding the Health Education Answers program to address the needs of Mandarin-speaking patients."

About Health Education Answers

Health Education Answers is based on research-supported patient education material that adheres to national clinical guidelines. This tool educates patients on several health areas, including proper diet and exercise, healthy habits to teach kids, and simple steps to help individuals and families prevent illness.

The program also includes an optional health risk assessment, which helps patients identify and understand their individual health needs and at-risk behaviors. Based on the results, Health Education Answers directs patients to the most applicable education modules that provide tips for improvement.

Awards and Recognition

In 2008, Health Education Answers received Health Information Product Certification from the National Committee for Quality Assurance (NCQA) for the Health Risk Appraisals and Interactive Consumer Health Tools certification options. NCQA is a private, nonprofit organization dedicated to providing health care quality information in order to help consumers, employers and others make more informed health care choices. Lilly was the first pharmaceutical company in the nation to receive this NCQA program status.

In addition, Health Education Answers received the 2009 Health Care Standard of Excellence Award from the Web Marketing Association. The annual WebAward Competition recognizes the people and organizations responsible for developing some of the most effective Web sites on the Internet today.

Additional Lilly Disease Management Programs

In addition to Health Education Answers, Lilly provides disease management information to multicultural populations through a variety of outreach efforts, including:

    --  Multicultural Health Care: A Quality Improvement Guide - a free tool and
        resource library for health care organizations that wish to reduce
        health disparities among the diverse communities they serve. The
        collaboration between Lilly and the National Committee for Quality
        Assurance walks organizations through four comprehensive steps for
        implementing a quality improvement process - assessment of gaps,
        development of a step-by-step plan to address needs, implementation of
        initiatives and evaluation of outcomes.

    --  Fearless African Americans Connected and Empowered (F.A.C.E.) Diabetes
        Campaign - a grass-roots movement empowering African Americans to help
        individuals, families and neighborhoods overcome key barriers to success
        in living with diabetes. The campaign implements a series of practical
        and sustainable programs, which help foster behavioral and attitudinal
        changes in areas critical to managing diabetes, such as nutrition and
        cooking, physical activity, health and overall well-being.

Additional information about Lilly's disease management programs is available on lillyforbetterhealth.com.

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(1) Asian-American Health Initiative, "Asian-Americans." Web site: http://www.aahiinfo.org/english/asianAmericans.php. Accessed September 17, 2009.

(2) United States Department of Commerce - U.S. Census Bureau. "Census Bureau Projects Doubling of Nation's Population by 2100." January 13, 2000. Press release.

(3) Joslin Diabetes Center, "Asian-Americans and Diabetes. Web site: http://www.joslin.org/managing_your_diabetes_4307.asp. Accessed September 15, 2009.

(4) Hughes, Dora, "Quality of Health Care for Asian-Americans," The Commonwealth Fund 2001 Health Care Quality Survey. March 2002.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

 
For full details on Eli Lilly & Company (LLY) click here. Eli Lilly & Company (LLY) has Short Term PowerRatings of 5. Details on Eli Lilly & Company (LLY) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [LLY]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.